6,633 Shares in Xylem Inc. $XYL Acquired by Virtu Financial LLC

Virtu Financial LLC bought a new position in shares of Xylem Inc. (NYSE:XYLFree Report) during the fourth quarter, HoldingsChannel.com reports. The firm bought 6,633 shares of the industrial products company’s stock, valued at approximately $903,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. J. Stern & Co. LLP grew its stake in shares of Xylem by 12,326.6% in the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares in the last quarter. Norges Bank acquired a new stake in shares of Xylem in the fourth quarter valued at $361,012,000. Schroder Investment Management Group boosted its holdings in Xylem by 2,055.2% in the third quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company’s stock valued at $171,687,000 after purchasing an additional 1,137,342 shares during the period. Balyasny Asset Management L.P. boosted its holdings in Xylem by 346.2% in the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after purchasing an additional 553,152 shares during the period. Finally, Adage Capital Partners GP L.L.C. acquired a new position in Xylem during the 2nd quarter worth $64,407,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on XYL shares. Oppenheimer cut their price target on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Weiss Ratings downgraded Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Stifel Nicolaus cut their target price on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. JPMorgan Chase & Co. reduced their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Finally, Barclays decreased their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average price target of $152.77.

Read Our Latest Research Report on Xylem

Insider Buying and Selling

In related news, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares in the company, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is currently owned by company insiders.

Xylem Stock Up 0.0%

Xylem stock opened at $111.44 on Monday. The stock has a market cap of $26.49 billion, a PE ratio of 27.72, a P/E/G ratio of 1.59 and a beta of 1.05. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The stock’s fifty day moving average is $114.53 and its two-hundred day moving average is $126.21. Xylem Inc. has a 1-year low of $105.29 and a 1-year high of $154.27.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the prior year, the firm posted $1.03 EPS. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be paid a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date is Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Xylem declared that its board has initiated a stock repurchase plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to reacquire up to 4.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Xylem Company Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.